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RESUmEn 
Objetivo: Evaluar la prevalencia de la co-
lonización nasal por Staphylococcus au-
reus en pacientes transplantados renales 
e identificar los factores de riesgo relacio-
nados. Método: Fueron recogidas mues-
tras nasales por medio de swabs de 160 
pacientes con hasta un año de hecho el 
transplante en el Hospital del Riñón e Hi-
pertensión. La recolección, el aislamiento, 
la identificación y el perfil de sensibilidad 
fueron llevados a cabo según las normas 
del National Committee for Clinical Labora-
tory Standards. Resultados: La prevalencia 
de colonización nasal por Staphylococcus 
aureus fue del 9,4% (15), siendo uno re-
sistente a la oxacilina (6,7%). Fue posible 
identificar como factor de riesgo asociado 
el tiempo de acceso para diálisis mayor 
de un año (p=0,029) previo al transplante. 
Conclusión: En virtud de la elevada mor-
bilidad y mortalidad causada por ese mi-
crorganismo en dicha población, se hace 
necesaria la realización de otros estudios, 
adoptándose el screening en los períodos 
pre y post transplante a fin de definir las 
estrategias de prevención y el control de la 
diseminación del Staphylococcus aureus.
dEScRiPtoRES 
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AbStRAct 
Objective: to evaluate the prevalence of 
Staphylococcus aureus nasal colonization 
in renal transplant patients and to identi-
fy the related risk factors. Method: Swabs 
were used to collect nasal samples from 
160 patients who had undergone a trans-
plant within the previous year at the Kid-
ney and Hypertension Hospital. The ‘Na-
tional Committee for Clinical Laboratory 
Standards’ norms were followed for the 
collection, isolation, identification and sen-
sitivity measurements. Results: There was 
a 9.4% (15) prevalence of Staphylococcus 
aureus nasal colonization, of which one 
(6.7%) was resistant to oxacillin. It was pos-
sible to identify as an associated risk factor 
a wait of more than one year for accessing 
dialysis prior to the transplant (p=0.029). 
Conclusion: Given the high morbidity and 
mortality rates that this microorganism 
causes in the target population, other stu-
dies should be carried out, and pre- and 
post-transplant screening should occur in 
order to develop strategies that improve 
the prevention and control of the spread of 
Staphylococcus aureus.
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RESUmo 
Objetivo: Avaliar a prevalência da coloni-
zação nasal por Staphylococcus aureus em 
pacientes transplantados renais e iden-
tificar os fatores de risco relacionados. 
Método: Foram coletadas amostras na-
sais por meio de swabs de 160 pacientes 
com até um ano de transplante realizado 
no Hospital do Rim e Hipertensão. A cole-
ta, isolamento, identificação e o perfil de 
sensibilidade foram realizados segundo as 
normas do National Committee for Clinical 
Laboratory Standards. Resultados: A pre-
valência de colonização nasal por Staphylo-
coccus aureus foi de 9,4% (15), sendo um 
resistente à oxacilina (6,7%). Foi possível 
identificar como fator de risco associado 
o tempo de acesso para diálise maior que 
um ano (p=0,029) prévio ao transplante. 
Conclusão: Devido à elevada morbidade 
e mortalidade causada por esse microrga-
nismo nessa população, faz-se necessária 
a realização de outros estudos, adotando 
o screening nos períodos pré e pós-trans-
plante para definir estratégias de preven-
ção e controle da disseminação do Sta-
phylococcus aureus.
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intRodUction
Hospital-acquired Staphylococcus aureus (S.aureus) 
infections result in 292 thousand hospitalizations and 
19 thousand deaths per year(1-2). In the USA, 28.6% of 
the population are thought to be infected and 1.5% 
to be oxacillin resistant (ORSA)(3). In patients with end 
stage renal disease (ESRD), S.aureus infection is the 
greatest cause of morbidity and the second most sig-
nificant cause of death, after cerebrovascular events(4). 
Colonization of the nasal passage and of the catheter 
insertion site in the population of dialysis patients 
is associated with the presence of infection(4-5), with 
an increase in infections of the blood stream and the 
need for surveillance and control measures(6-7). In Bra-
zil, 11,436 renal transplants were carried out between 
2007 and 2009, of which 4,632 (40.5%) occurred in 
Sao Paulo state. Of these, 2,170 (46.8%) took place at 
the Kidney and Hypertension Hospital (HRim) and at 
the Federal University of Sao Paulo, UNIFESP(8). The in-
crease in the number of kidney transplant patients is a 
challenge, since survival rates are continually improv-
ing, patients are older and there is a greater number 
of comorbidities. As a result, there is a need for more 
regular monitoring and there has been a rise in the 
number of hospitalizations for treatment meaning an 
increase in prior contact with microorganisms such as 
S.aureus and other agents of hospital infection. Studies 
of the colonization and infection of S.aureus have been 
carried out on dialysis patients, and have shown an in-
creased prevalence of the agent and a direct relation-
ship with cases of endocarditis(9-10). Recently, molecular 
typing has served to show that cross infection by multi-
resistant microorganisms occurs in dialysis and renal 
transplant patients that were monitored during treat-
ment (11). Another important element is that patients 
who undergo renal transplants are particularly suscep-
tible to colonization not only arising from dialysis, but 
also because they experience greater immunosuppres-
sion, particularly in the first year after receiving the 
transplant (12). Data is not available regarding S.aureus 
colonization in kidney transplant receptors, therefore 
this study could help to establish an endemic level of 
colonization of this agent in renal graft receptors, and 
to support actions aimed at preventing and controlling 
the spread of this microorganism. Given this context, 
the objectives of this study were to evaluate the preva-
lence of S.aureus nasal colonization in renal transplant 
patients and to identify the related risk factors for pa-
tients infected by S.aureus. 
mEtHodS
Ethical considerations: The study received approval 
(number 592/04) from the Research Ethics Committee 
at the Federal University of Sao Paulo, UNIFESP and in-
volved the signing of clear and free consent forms.
Design, period and location of the study: This trans-
versal study took place between March 2009 and De-
cember 2011 at the HRim university hospital at UNIFESP, 
which is considered to an institution of international 
excellence which is responsible for around 900 to 1,000 
transplants per year.
Population and sample: On the basis of an estimat-
ed 30% prevalence of S.aureus colonization in a healthy 
population and an error estimate of around 7%, consid-
ering a type I error of 5% and a type II error of 20% in the 
effected population, 160 patients were included in the 
study. For the prevalence analysis the study sample was 
made up of patients over the age of 18, and divided up 
according to the immunosuppression protocols adopted: 
60 patients with up to 30 days of transplant (loading 
dose), 50 patients with between two and six months (ad-
equacy dose) and 50 patients with between six months 
and a year (maintenance dose). The patients who had 
most recently undergone transplant were evaluated 
within the hospital soon after the transplant, while the 
other groups were made up of patients that were chosen 
at random from outpatient facilities for renal transplant 
at UNIFESP. Those patients that did not give their con-
sent to participate in the study were excluded.
Study protocol: A registry was prepared containing 
data that enabled clinical identification: sex, age, race, 
primary renal illness, type of dialysis and time and di-
alysis access prior to the transplant, human leukocyte 
antigen (HLA) pairing, blood transfusions prior to the 
transplant and type of immunosuppressive treatment. 
From the medical records, information was collected 
regarding the result of the microbiological analysis and 
relevant infection during the period post-transplant.
Laboratory Methodology: A single nasal sample was 
collected from one nostril of each of the 160 patients. 
Nasal collection was chosen given the direct relationship 
between the nasal carrier and the risk of infection by the 
agent. Alginate swabs that had been dampened with ster-
ile lactated Ringer’s solution were used for the collection 
of the nasal sample. The swab was introduced to the low-
er region of the nostril and delicately twisted. Once the 
collection had been carried out, the swab was soaked in 
BHI solution (tubes containing 2.5ml of Brain Heart Infu-
sion - BHI, Difco). After incubating at 35oC for 18 to 24 
hours, the samples in the BHI solution were cultivated in 
agar blood containers (Columbia Blood Agar, Difco, en-
riched with 5% sheep’s blood) with or without oxacillin, 
and Mannitol salt agar (Difco). After 24 hours, the contain-
ers were examined to check for growth of the bacterial 
colonies and were identified using classical biochemical 
tests(13). The tests for isolated strains to determine resis-
tance to oxacillin were carried out using the disk diffusion 
method, following the norms established by the National 
Committee for Clinical Laboratory Standards (NCCLS) (14). 
The laboratory procedures were performed in the Special 
Clinical Microbiology Laboratory at UNIFESP.
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Statistical analysis and results: For the analysis of 
results, the patients were considered as being colo-
nized or not by the S.aureus. The analysis of results 
with regard to the time since transplant was carried 
out for those patients who were infected by the micro-
organism. The method included a descriptive analysis, 
taking into account clinical and laboratory variables 
and parameters related to the transplant. A bivariate 
analysis followed in which the groups (infected or not) 
were compared. For continual variables, Student’s t-
test or the Mann-Whitney test were applied, when 
appropriate. Categorical variables were tested using 
the chi square of Fisher’s exact test. The tests that were 
applied were two tailed, and the significance level used 
was p < 0.05(15).
RESULtS
Demographic data relating to patients with and with-
out S.aureus are presented in Table 1, along with the clini-
cal characteristics prior to the renal transplant. 
Table 1 – Demographic and clinical characteristics prior to the transplant of renal receptors, Sao Paulo, 2011
Characteristics
Staphylococcus aureus Negative
p
n=15 % n=145 %
Sex
0.417Masculine 11 73.3 91 62.8
Feminine 4 26.7 54 37.2
Age X± DP 41.3± 11.9 41.7± 10.8 0.904
Ethnicity 
0.651White 10 66.7 88 60.7
Non White 5 33.3 57 39.3
Treatment prior to transplant
Hemodialysis 15 100.0 125 86.2
0.307Peritoneal dialysis 13 9.0
Conservative care 7 4.8
Time since access
0.029> 1 year 14 93.3 89 61.4
< 1 year 1 6.7 56 38.6
Blood transfusions 3 20.0 14 9.7 0.202
Primary renal illness 
Indeterminate 8 53.3 28 19.3
0.028
Hypertension 2 13.3 36 24.8
Glomerulonephritis 2 13.3 22 15.2
Other 3 20.0 59 40.7
Among the colonized patients, 11 (73.3%) were male 
and 10 (66.7%) were white. All had carried out hemodi-
alysis prior to the transplant, and 93.3% had made their 
first venal access at least a year previously. Of these, 
13 (86.7%) carried out the dialysis through an arterio-
venous fistula and two (13.3%) using a central venous 
catheter. Among the colonized patients, eight (53.3%) 
had undetermined primary renal illness.  There was a 
statistically significant association between access time 
of a year or more in dialysis (p=0.02) and undetermined 
primary renal illness (p=002) with nasal colonization by 
S.aureus. At the center where the study was carried out, 
an antimicrobial prophylaxis is carried out on 100% of 
transplant patients. Cefalexin (cephalosporin) is used to 
prevent infection at the surgical site for 48 hours after 
the transplant, and sulfamethoxazole / Trimethoprim 
(SMT) is used for at least a year to prevent opportun-
ist infections occurring subsequent to the transplant. 
Of the patients with nasal colonization by S.aureus, 12 
(80%) used SMT immediately after the transplant and 10 
(66.7%) used cephalosporins.
In Table 2, we present the characteristics of the trans-
plant, along with donor and immunosuppression type.
Continued...
Table 2 – Transplant characteristics, type of donor and immunosuppression – Sao Paulo, 2011
Characteristics 
Staphylococcus aureus Negative
p
n=15 % n=145 %
Renal donor
0.175HLA I and II 8 53.3 83 57.2
HLA III and deceased donor 7 46.7 62 42.8
Immunosuppressant drugs
Mycophenolate mofetil 4 26.7 34 23.4 0.756
Tacrolimus 7 46.7 55 37.9 0.509
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the relative risk of infection by S.aureus was 3.42 times 
greater (IC 95%; 2.40 – 4.88). The persistence of S.aureus 
colonization was associated with an increase in infection 
rates. The authors suggested that on-going monitoring 
was required in order to detect the emergence of new 
patients infected(16). 
A separate prospective study monitored patients col-
onized by ORSA that had been admitted to five hospital 
units (medico-surgical clinics, clinical intensive care units – 
ICUs, surgical ICUs, trauma ICUs and semi-intensive units). 
Nasal samples were collected and the patients were moni-
tored for one year. Of the 758 patients monitored since 
admission, 3.4% were colonized by ORSA and 21% by OS-
SA. A total of 19% of patients with ORSA upon admission 
and 25% who had become infected after admission devel-
oped the infection compared with 1.5% of patients colo-
nized by OSSA (p<0.01) and 2.0% not colonized (p<0.01). 
The authors suggested that monitoring and accompani-
ment strategies were required for colonized patients in 
order to reduce the infections caused by ORSA(17).
A multicenter prospective study was carried out at 
14 intensive therapy units in France over a six month 
period and detected the prevalence of nasal carriers of 
ORSA upon admission at these units. Of 2,347 patients 
admitted, 162 (6.9%) were ORSA positive. In patients 
that had been readmitted, the prevalence of ORSA was 
22.2%. In a multivariate analysis, the risk factors associ-
ated with nasal carriers of ORSA were: age over 60, pro-
longed period of hospitalization, history of hospitaliza-
tion or surgery and presence of open skin lesions. The 
author suggested that nasal swabs should be collected 
There was no statistically significant association be-
tween the state of the S.aureus carrier and the character-
istics of the renal transplant, donor type or immunosup-
pressant drugs used.
The prevalence of colonization by S.aureus found in 
this population was 9.4%. 14 (93.3%) of this group had 
S.aureus that was sensitive to oxacillin (OSSA) and one 
(6.7%) was oxacillin resistant (ORSA). In Table 3 we pres-
ent the prevalence of S.aureus colonization by time of 
renal transplant and immunosuppression protocol.
The analysis of colonization prevalence according to im-
munosuppressant protocols adopted during Service for pa-
tients up to 30 days since transplant (loading dosage), those 
after between two and six months (adequacy dosage) and 
between six months and a year (maintenance dosage) show 
that the isolation rates of the microorganism were 60%, 
13.3% and 26.7% respectively, with statistical significance 
(p<0.05) in the prevalence in all cases.
Table 3 – Isolation of nasal S.aureus from renal receptors, in relation to time of transplant and immunosuppressant dosage – Sao 
Paulo, 2011
Time of transplant and immunosuppressant dosage 
Staphylococcus aureus Negative
p(*)
n=15 % n=145 %
Up to 30 days/loading dosage (n= 60) 9 60.0* 51 35.2
<0.0560 to 180 days/loading dosage (n=50) 2 13.3* 48 33.1
180 days – 1 year  / maintenance dosage (n=50) 4 26.7* 46 31.7
Total 15 100 145 100
diScUSSion
The high rates of morbidity and mortality related 
to S.aureus among patients who have undergone renal 
transplant highlight the need and importance of defin-
ing healthcare strategies to prevent the colonization 
and transmission of this microorganism in this specific 
group(12). Between 1995 and 2002, the percentage of di-
alysis centers in the USA that treated one or more pa-
tients with ORSA increased from 40% to 70%. Between 
1997 and 2000, five of every six patients diagnosed with 
S.aureus and with intermediary resistance to vancomy-
cin had carried out dialysis. In 2005, ORSA infections of 
the bloodstream were found to occur in 45.2 of every 
1,000 dialysis patients(6). In kidney transplant patients, 
the initial intense immunosuppression associated with 
the invasive procedures carried out in the period pre and 
post-transplant increase the risk of infections by micro-
organisms, with the most common being S.aureus. In pa-
tients with ESRD, there is greater exposure to risk factors 
related to colonization and infection by the agent, both 
in the substitute therapy period and in the phases before 
and after the transplant. 
A study conducted at the peritoneal dialysis clinic in a 
university hospital surveyed 98 patients to determine the 
nasal colonization and the outlet site of the peritoneal 
catheter for S.aureus. All samples were OSSA and 44% of 
patients were considered to suffer from chronic coloni-
zation of the microorganism. The relative risk of any in-
fection in chronic carriers, compared to intermittent car-
riers, was 2.91 times greater (IC 95%; 2.17 – 3.90), and 
Characteristics 
Staphylococcus aureus Negative
p
n=15 % n=145 %
Ciclosporin 8 53.3 80 55.2 0.892
Azathioprine 2 66.7 98 67.6 0.999
Prednisone 14 93.3 144 99.3 0.179
Continuation...
828 Rev Esc Enferm USP2014; 48(5):824-30www.ee.usp.br/reeusp/
Prevalence of Staphylococcus aureus colonization 
in renal transplant patients
Lamblet LCR, Barbosa DA
as routine in patients admitted to intensive therapies, in 
order to identify those who were carriers and to insti-
gate control measures(18).
The prevalence of nasal colonization is as common 
in renal patients as it is in their family members and in 
healthcare professionals. An East Asian study evaluated 
the nasal colonization, infection and transmission rate of 
Staphylococcus aureus in patients from the dialysis pro-
gram, along with their family members and health pro-
fessionals. Of the 1,687 samples collected in a year, in 
three periods, the colonization rate for ORSA was 2.41% 
(2/83) in peritoneal dialysis and 2.36% (12/509) in he-
modialysis. Of these patients, five (5/14) were infected 
by ORSA with similar clinical and colonization samples, 
showing that the colonization preceded the infection(19).
A study carried out in a Brazilian hospital evaluated 
nasal and palm colonization of 151 nursing professionals 
that worked in the surgery center, the intensive care unit 
and in nephrology/hemodialysis. Of the 302 samples col-
lected, 25.8% were positive for S.aureus. Of the 39 pro-
fessionals infected, 25.6% had positive samples on their 
hands, 48.8% had positive nasal samples and 25.6% had 
both. Of the five positive ORSA samples (3.3%), all were 
found in the nasal sample(20).
A number of studies have reported on the need for 
multiple strategies to reduce S.aureus infections. One 
such study describes the actions adopted that resulted 
in an 82% reduction in ORSA infections in two units for 
patients in critical conditions, which included nasal sam-
ples upon admission, release and transferal of patients, 
precautions regarding contact, and other measures. In 
the four years after establishing these procedures, there 
was a decrease in ORSA infections from 1.4 infections per 
patient/day to 0.27(21). Some authors have studied strate-
gies for nasal decolonization and its impact in the reduc-
tion of infections in situations where S.aureus became 
highly prevalent, as well as the benefits and risks of these 
measures. The CDC and APIC recommendations to avoid 
the spread of ORSA include nasal decolonization in spe-
cific situations, including the use of antibiotics(22-23). These 
data confirm the importance of studying the prevalence 
of S.aureus among kidney transplant patients, given that 
there is little information available on nasal colonization 
by the agent in this group of patients and in view of the 
associated risks.
A different study involved a retrospective investiga-
tion in the period of a year in order to compare micro-
bial resistance in 207 diabetic patients divided into three 
groups: those who had undergone a kidney transplant 
(n=21), hemodialysis (n=22) and other patients (n=164). 
S.aureus was the second most common agent in the 
three groups, with a 21% S55% and 32% respectively(24). 
A retrospective study analyzed the incidence of perito-
nitis up to 90 days after the renal transplant. Between 1980 
and 1995, 238 transplants were carried out in patients who 
underwent peritoneal dialysis.  Of the 232 cases evaluated, 
30 episodes of peritonitis were found. Of these, 10 (33.3%) 
were for S.aureus. Seven patients had peritonitis from 
S.aureus prior to the transplant and this was found to be 
the principle risk factor in a univariate analysis. The hypoth-
esis presented by the authors was that the patients were 
nasal carriers of S.aureus(25).
A case study described enterocolitis with ulceration and 
perforation of the colon on the fifth day after renal trans-
plant in a 46 year-old patient. Cultures from abdominal 
and pos-mortem material showed that the disease/infec-
tion was caused by ORSA(26). This result was presented in 
a study of 159 patients in which nasal samples were col-
lected from patients who had undergone kidney transplant 
or who were undertaking dialysis. Nasal colonization of 
S.aureus was found in 75% (36/48) of the transplant pa-
tients and in 49% (55/111) of dialysis patients, highlighting 
the need for prevention and control measures in this group 
of patients(27).
Knowing the colonization rate of patients would allow 
for the creation of strategies to avoid the dissemination of 
microorganisms and the development of resistance to gly-
copeptides, with the growth of resistant strains. S.aureus 
can be isolated from other regions of the body, such as the 
armpits and perineum(5).
One of the limitations of this study is the fact that the 
collection was carried out just once and only in the na-
sal region. In addition, it was not possible to carry out a 
follow-up with patients to determine whether they were 
intermittent or chronic carriers of S.aureus. At the center 
where the study was carried out an antimicrobial prophy-
laxis is administered to 100% of transplant patients.  A 
nasal collection was not performed prior to the inclusion 
of the patient in the study, which could have determined 
if the use of antibiotics that began in the period immedi-
ately after transplant surgery could have been a factor in 
the decolonization of patients who had previously been 
colonized. Of all the patients for whom samples were col-
lected, 140 (87.5%) used SMT after the transplant. How-
ever, of the 15 patients colonized by S.aureus, nine (60%) 
had been using antibiotics for just two days. Is it possible 
that in the group of patients that had negative results for 
S.aureus, this antibiotic had a protective effect and in the 
colonizers the short period of use meant that decoloniza-
tion had not yet been instigated? Studies are required in 
order to establish the protective effect of the antibiotic. 
The use of antibiotics, collected previously, is a theme 
that deserves further investigation.  We believe collection 
should be increased to other colonization sites, such as 
the perineal and axillary regions, and that cultures should 
be gathered prior to transplant.
The statistical analysis showed that indeterminate 
primary renal illness was significant among patients in-
fected with S.aureus (p=0.02). This finding highlights a 
study limitation, since in the medical records that were 
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studied it was not possible to obtain information about 
specific patients with the illness. Many patients are for-
warded to the service with the primary cause being in-
determinate renal insufficiency, since there are failures 
in epidemiological information about the illness. There 
was a statistically significant association between ac-
cess time greater than one year in dialysis (p=0.02) and 
S.aureus nasal colonization. Of the 15 patients colonized, 
13 (86.7%) were undergoing hemodialysis by means of 
an arteriovenous fistula and two (13.3%) through a cen-
tral venous catheter. Other studies have shown the re-
lationship between nasal colonization, catheter site and 
increased risk of infection among patients with ESRD (4-
7, 16). The finding highlights the need to review antisep-
sis practices and those relating to the manipulation of 
the arteriovenous fistula. The statistically significant dif-
ference (p<0.05) between the prevalence of colonization 
according to immunosuppression protocols for patients 
with up to 30 days of transplant (loading dosage), those 
with between two and six months (adequacy dosage) 
and more than six months (maintenance dosage) shows 
and reinforces the need for greater surveillance of the 
state of the nasal carrier in this population of patients. It 
is probable that this evaluation might determine defini-
tively whether a specific action, intervention or treat-
ment that is applied to the patient with ESRD has had a 
beneficial or protective effect on the state of the nasal 
carrier of S.aureus. 
concLUSion
The prevalence in the present study showed 15 kidney 
recipient patients infected with S.aureus (9.4%) and one 
of these (6.7%) was colonized by ORSA. The risk factors in 
the study that showed statistical significance in a bivari-
ate analysis were access time prior to transplant (p=0.029) 
and indeterminate primary renal illness (p=0.029). On 
the basis of these findings and the detection of this num-
ber of patients as nasal carriers and the low incidence of 
ORSA, we recommend a screening of patients treated at 
the dialysis center and of renal transplant patients. New 
studies are necessary to determine strategies to prevent 
the transmission of microorganisms, principally during the 
first year of renal transplant.
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